Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Tagraxofusp is an agent that consists of interleukin-3 fused to a truncated diphtheria toxin, targeting CD123 (1)
Tagraxofusp (ELZONRIS TM) is approved by both the FDA and EMA for treatment of adult and pediatric patients 2 years and older with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), with slightly different population/line restrictions in the US vs EU (1, 2, 3, 4, 5)
Basis: …